Loading…
Immune Responses to Invasive Group B Streptococcal Disease in Adults
Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infecti...
Saved in:
Published in: | Emerging infectious diseases 2016-11, Vol.22 (11), p.1877-1883 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1883 |
container_issue | 11 |
container_start_page | 1877 |
container_title | Emerging infectious diseases |
container_volume | 22 |
creator | Edwards, Morven S Rench, Marcia A Rinaudo, C Daniela Fabbrini, Monica Tuscano, Giovanna Buffi, Giada Bartolini, Erika Bonacci, Stefano Baker, Carol J Margarit, Immaculada |
description | Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable. |
doi_str_mv | 10.3201/eid2211.160914 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A472266308</galeid><doaj_id>oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b</doaj_id><sourcerecordid>A472266308</sourcerecordid><originalsourceid>FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3</originalsourceid><addsrcrecordid>eNqN0t9r1TAUB_Aiivuhrz5KQZD50Gt-NUkfr5vOwmCwqa_lNDm9y2ibrkmH_vdm3jm8cB8kDwmHz_kGTpJlbyhZcUboR3SWMUpXVJKKimfZISWaFJKU1fOnsyAH2VEIt4TQ1FK9zA6YUlIRog-zs3oYlhHzKwyTHwOGPPq8Hu8huHvMz2e_TPmn_DrOOEVvvDHQ52cuIATM3Ziv7dLH8Cp70UEf8PXjfpx9__L52-nX4uLyvD5dXxRWaBoLCaBYaYhmVLSqEwx1CaQUpGKWaAlC6jJdYFpBWFkprWknEDTnSnHaasuPs3qbaz3cNtPsBph_NR5c86fg500Dc3Smx4a13EpoLShRCcOrSrUtbZWl0ipiVZuyTrZZ0-zvFgyxGVww2Pcwol9CQzUvy4epskTfbekGUrIbOx9nMA-8WQvFmJSc6KSKPWqDI87Q-xE7l8o7frXHp2VxcGZvw4edhmQi_owbWEJo6uur_7eXP3bt-3_sDUIfb4Lvl-jSh9iFbx9HtrQD2qcH-Pub-G_Jt8Th</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835516092</pqid></control><display><type>article</type><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><source>PubMed Central</source><creator>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</creator><creatorcontrib>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</creatorcontrib><description>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid2211.160914</identifier><identifier>PMID: 27767008</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adult ; adult invasive infection ; Aged ; Aged, 80 and over ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - immunology ; Antibody Specificity - immunology ; Bacteremia ; bacteria ; capsular polysaccharide ; Development and progression ; Female ; group B Streptococcus ; Humans ; Immune response ; Immunoglobulin G - blood ; Immunoglobulin G - immunology ; Male ; Middle Aged ; Molecular Typing ; pilus island ; Polysaccharides, Bacterial - immunology ; Serotyping ; Streptococcal infections ; Streptococcal Infections - diagnosis ; Streptococcal Infections - immunology ; Streptococcal Infections - microbiology ; Streptococcus agalactiae - classification ; Streptococcus agalactiae - genetics ; Streptococcus agalactiae - immunology ; Streptococcus agalactiae - isolation & purification ; Testing</subject><ispartof>Emerging infectious diseases, 2016-11, Vol.22 (11), p.1877-1883</ispartof><rights>COPYRIGHT 2016 U.S. National Center for Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27767008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Edwards, Morven S</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Rinaudo, C Daniela</creatorcontrib><creatorcontrib>Fabbrini, Monica</creatorcontrib><creatorcontrib>Tuscano, Giovanna</creatorcontrib><creatorcontrib>Buffi, Giada</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Bonacci, Stefano</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Margarit, Immaculada</creatorcontrib><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</description><subject>Adult</subject><subject>adult invasive infection</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - immunology</subject><subject>Antibody Specificity - immunology</subject><subject>Bacteremia</subject><subject>bacteria</subject><subject>capsular polysaccharide</subject><subject>Development and progression</subject><subject>Female</subject><subject>group B Streptococcus</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Typing</subject><subject>pilus island</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Serotyping</subject><subject>Streptococcal infections</subject><subject>Streptococcal Infections - diagnosis</subject><subject>Streptococcal Infections - immunology</subject><subject>Streptococcal Infections - microbiology</subject><subject>Streptococcus agalactiae - classification</subject><subject>Streptococcus agalactiae - genetics</subject><subject>Streptococcus agalactiae - immunology</subject><subject>Streptococcus agalactiae - isolation & purification</subject><subject>Testing</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqN0t9r1TAUB_Aiivuhrz5KQZD50Gt-NUkfr5vOwmCwqa_lNDm9y2ibrkmH_vdm3jm8cB8kDwmHz_kGTpJlbyhZcUboR3SWMUpXVJKKimfZISWaFJKU1fOnsyAH2VEIt4TQ1FK9zA6YUlIRog-zs3oYlhHzKwyTHwOGPPq8Hu8huHvMz2e_TPmn_DrOOEVvvDHQ52cuIATM3Ziv7dLH8Cp70UEf8PXjfpx9__L52-nX4uLyvD5dXxRWaBoLCaBYaYhmVLSqEwx1CaQUpGKWaAlC6jJdYFpBWFkprWknEDTnSnHaasuPs3qbaz3cNtPsBph_NR5c86fg500Dc3Smx4a13EpoLShRCcOrSrUtbZWl0ipiVZuyTrZZ0-zvFgyxGVww2Pcwol9CQzUvy4epskTfbekGUrIbOx9nMA-8WQvFmJSc6KSKPWqDI87Q-xE7l8o7frXHp2VxcGZvw4edhmQi_owbWEJo6uur_7eXP3bt-3_sDUIfb4Lvl-jSh9iFbx9HtrQD2qcH-Pub-G_Jt8Th</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Edwards, Morven S</creator><creator>Rench, Marcia A</creator><creator>Rinaudo, C Daniela</creator><creator>Fabbrini, Monica</creator><creator>Tuscano, Giovanna</creator><creator>Buffi, Giada</creator><creator>Bartolini, Erika</creator><creator>Bonacci, Stefano</creator><creator>Baker, Carol J</creator><creator>Margarit, Immaculada</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>IOV</scope><scope>ISR</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>201611</creationdate><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><author>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>adult invasive infection</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - immunology</topic><topic>Antibody Specificity - immunology</topic><topic>Bacteremia</topic><topic>bacteria</topic><topic>capsular polysaccharide</topic><topic>Development and progression</topic><topic>Female</topic><topic>group B Streptococcus</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Typing</topic><topic>pilus island</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Serotyping</topic><topic>Streptococcal infections</topic><topic>Streptococcal Infections - diagnosis</topic><topic>Streptococcal Infections - immunology</topic><topic>Streptococcal Infections - microbiology</topic><topic>Streptococcus agalactiae - classification</topic><topic>Streptococcus agalactiae - genetics</topic><topic>Streptococcus agalactiae - immunology</topic><topic>Streptococcus agalactiae - isolation & purification</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Edwards, Morven S</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Rinaudo, C Daniela</creatorcontrib><creatorcontrib>Fabbrini, Monica</creatorcontrib><creatorcontrib>Tuscano, Giovanna</creatorcontrib><creatorcontrib>Buffi, Giada</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Bonacci, Stefano</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Margarit, Immaculada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Edwards, Morven S</au><au>Rench, Marcia A</au><au>Rinaudo, C Daniela</au><au>Fabbrini, Monica</au><au>Tuscano, Giovanna</au><au>Buffi, Giada</au><au>Bartolini, Erika</au><au>Bonacci, Stefano</au><au>Baker, Carol J</au><au>Margarit, Immaculada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune Responses to Invasive Group B Streptococcal Disease in Adults</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2016-11</date><risdate>2016</risdate><volume>22</volume><issue>11</issue><spage>1877</spage><epage>1883</epage><pages>1877-1883</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>27767008</pmid><doi>10.3201/eid2211.160914</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1080-6040 |
ispartof | Emerging infectious diseases, 2016-11, Vol.22 (11), p.1877-1883 |
issn | 1080-6040 1080-6059 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b |
source | PubMed Central |
subjects | Adult adult invasive infection Aged Aged, 80 and over Antibodies, Bacterial - blood Antibodies, Bacterial - immunology Antibody Specificity - immunology Bacteremia bacteria capsular polysaccharide Development and progression Female group B Streptococcus Humans Immune response Immunoglobulin G - blood Immunoglobulin G - immunology Male Middle Aged Molecular Typing pilus island Polysaccharides, Bacterial - immunology Serotyping Streptococcal infections Streptococcal Infections - diagnosis Streptococcal Infections - immunology Streptococcal Infections - microbiology Streptococcus agalactiae - classification Streptococcus agalactiae - genetics Streptococcus agalactiae - immunology Streptococcus agalactiae - isolation & purification Testing |
title | Immune Responses to Invasive Group B Streptococcal Disease in Adults |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A53%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20Responses%20to%20Invasive%20Group%20B%20Streptococcal%20Disease%20in%20Adults&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Edwards,%20Morven%20S&rft.date=2016-11&rft.volume=22&rft.issue=11&rft.spage=1877&rft.epage=1883&rft.pages=1877-1883&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid2211.160914&rft_dat=%3Cgale_doaj_%3EA472266308%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835516092&rft_id=info:pmid/27767008&rft_galeid=A472266308&rfr_iscdi=true |